The tweet was deleted by the author.
But we saved everything 🙂.
Stereotaxis reported late-breaking clinical data featuring its next generation RStar system at TCT2026. The data focused on outcomes from robotic-assisted percutaneous coronary intervention (PCI) using the advanced technology, as highlighted alongside Robocath.
The results showcase ongoing innovation in robotic interventions within cardiovascular medicine, with industry stakeholders closely observing advancements in this field.
View post on X Loading...
Stereotaxis recently launched its MAGiC ablation tip, designed to improve consistency in tissue contact and energy delivery for medical procedures, according to a past product debut announcement. The company also introduced the GenesisX system to expand the reach of robotic electrophysiology in cath labs and enhance patient care, as detailed in a separate report. These developments reflect Stereotaxis's ongoing efforts to advance its robotic platforms in cardiovascular medicine.